ROLLINS INC
No SEC Form 4 filings for $ROL in the last 30 days.
See all $ROL insider activity →Orkin, a pest control brand under Rollins, acquired JNJ Pest Control in Newburgh, New York. The deal closed April 13, with Cetane Associates advising JNJ. Orkin said the purchase strengthens its New York presence and that JNJ customers will receive the same service level. The transaction highlights consolidation in a fragmented industry.
MEXC says AAPL, IBM, and ROL stock futures will undergo cash dividend settlement tied to each underlying company’s dividend schedule. Futures enter reduce-only on Aug 9, 2026 23:30 UTC, settlement occurs Aug 10 00:00 UTC, then normal trading resumes at 00:05. Longs receive, shorts pay via funding fee adjustments based on position snapshots.
Rollins, Inc. reported Q2 2026 operating margin of 18.7%, down 110 bps year over year, and operating cash flow of $173 million, down 1.5%. CEO Jerry Gahlhoff said results missed expectations due to a weaker lead environment and fewer customers using digital pest-control searches. Rollins shares fell about 9.27%.
Over the past 7 days, alphai's AI scored 1 news story mentioning ROL (ROLLINS INC). Coverage has skewed bullish: 1 bullish, 0 neutral, and 0 bearish.
Recent ROL coverage spans financial news, earnings and market movers.
Deal supports Rollins' geographic expansion via its Orkin brand, but financial impact is not quantified in the article.
ROL futures traders face potential margin shortfalls if short, and margin pressure if long, due to ex-dividend price decline and settlement deductions.
Margin compression tied to a worsening lead environment and fewer digital pest-control searches increases near-term earnings risk.
Analyst rating and price-target reiteration provides limited incremental information versus prior consensus, but can influence near-term sentiment.
Analyst downgrade with sharply lower PT and revised revenue, EBITDA margin, and EPS estimates increases near-term downside risk for ROL sentiment and expectations.
alphai scores every news story that mentions ROL with an AI model for sentiment and relevance, and aggregates insider trades from ROLLINS INC's SEC EDGAR Form 4 filings. Figures refresh continuously.
Orkin, a pest control brand under Rollins, acquired JNJ Pest Control in Newburgh, New York. The deal closed April 13, with Cetane Associates advising JNJ. Orkin said the purchase strengthens its New York presence and that JNJ customers will receive the same service level. The transaction highlights consolidation in a fragmented industry.
2 min readMEXC says AAPL, IBM, and ROL stock futures will undergo cash dividend settlement tied to each underlying company’s dividend schedule. Futures enter reduce-only on Aug 9, 2026 23:30 UTC, settlement occurs Aug 10 00:00 UTC, then normal trading resumes at 00:05. Longs receive, shorts pay via funding fee adjustments based on position snapshots.
1 min readRollins, Inc. reported Q2 2026 operating margin of 18.7%, down 110 bps year over year, and operating cash flow of $173 million, down 1.5%. CEO Jerry Gahlhoff said results missed expectations due to a weaker lead environment and fewer customers using digital pest-control searches. Rollins shares fell about 9.27%.
4 min readUBS analyst Joshua Chan reiterated a Hold rating on Rollins (ROL) and set a $43.00 price target. Other coverage cited includes Hold ratings from Canaccord Genuity and a Buy from Barclays. Rollins reported Q2 revenue of $1.08B and net profit of $143.91M, up from $999.53M revenue and $141.49M net profit a year earlier.
2 min readJPMorgan downgraded Rollins to Neutral from Overweight and cut its price target to $45 from $70, citing uncertainty from weakening residential demand and a slower margin recovery. It lowered fiscal 2026/2027 revenue growth forecasts to 8.7% and 8.4%, adjusted EBITDA margins to 21.9% and 22.2%, and adjusted EPS to $1.17 and $1.26. The move follows a weaker Q2 with declining lead volumes.
3 min readPiper Sandler lowered its Rollins (NYSE:ROL) stock price target to $46 from $72 and kept an “overweight” rating, citing updated expectations. Other analysts also cut targets, including Wells Fargo to $32 and UBS reaffirming $43. ROL traded at $38.51 after Q2 EPS of $0.32 vs $0.34 consensus.
4 min readWall Street analysts issued multiple rating changes. Truist upgraded PayPal (PYPL) to Hold, $57 target; Leerink upgraded Edwards Lifesciences (EW) to Outperform, $101. TD Cowen upgraded Digital Realty (DLR) to Buy, $222; Morgan Stanley upgraded Progressive (PGR) to Equal Weight, $210. Several downgrades followed, including Infosys (INFY) and Albertsons (ACI). Coverage initiations included SpaceX (SPCX) and Chime (CHYM).
2 min readUBS cut its price target on Rollins (ROL) to $43 from $50 and kept a Neutral rating, according to the note. The article also cites BNP Paribas raising its target to $44 from $63 with a Neutral rating. Rollins last traded at $39.44, with an average analyst target of $47.94.
2 min readRollins Inc (NYSE:ROL) reported Q2 results after the close. Earnings were 32 cents per share versus a 34-cent consensus, and sales were $1.079 billion versus $1.092 billion expected. Shares fell 1.7% to $38.78 premarket. After the report, JP Morgan cut its target to $45 from $70 and downgraded to Neutral, while Wells Fargo cut to $32 from $46 and downgraded to Underweight.
2 min readWells Fargo downgraded Rollins (ROL) to underweight from equal weight and cut its price target to $32 from $46, citing softer residential pest-control demand. The bank cited headwinds including weather, potential impacts from LLMs, more aggressive competition, and more price-sensitive consumers. Rollins reported 5.7% organic growth, missed Q2 estimates, and lowered FY2026 guidance to about 6%.
6 min read
